Chugai Pharmaceutical Co., Ltd. (the “Company”) hereby announces that the Company, at the Annual General Meeting of Shareholders held on March 30, 2023, resolved the Year-End dividend for the fiscal year ending December, 2022 as follows.

1. Year-End Dividend:
   JPY 40 per share of common stock of the Company
2. Date when dividend of surplus becomes effective:
   March 31 (Friday), 2023